期刊文献+

Does surgical resection of hepatocellular carcinoma accelerate cancer dissemination? 被引量:6

Does surgical resection of hepatocellular carcinoma accelerate cancer dissemination?
暂未订购
导出
摘要 AIM: This study was to investigate whether surgery could increase cancer dissemination and postoperative recurrence in patients with hepatocellular carcinoma (HCC) by detection of human α-fetoprotein messenger RNA (hAFP mRNA), hAFP mRNA in the peripheral blood of patients with HCC has been considered as a surrogate marker for circulating tumor cells. METHODS: Eighty-one consecutive patients who underwent curative resection for HCC entered this prospective cohort study. We examined hAFP mRNA from the peripheral blood obtained preoperatively, perioperatively, and postoperatively to correlate the prognosis after curative resections from HCC patients and from the control subjects. Detection of hAFP mRNA by reverse transcriptase and polymerase chain reaction amplification (RT-PCR) was performed with primers specifically. The relations between the clinical variables (age,sex, associated liver cirrhosis, hepatitis B virus infection,hepatitis C virus infection, serum α-fetoprotein and ChildPugh class), the histological variables (size, capsule, vascular permeation, grade of differentiation, and daughter nodules),hAFP mRNA in peripheral blood of 3 different sessions, and postoperative course (recurrence, and recurrence related death) were analysed. RESULTS: No hAFP mRNA was detected in control group subjects. Twenty-two (27%), 24 (30%) and 19 (23%) of 81 HCC patients had hAFP mRNA positivity in the preoperative,perioperative and postoperative peripheral blood. The preoperative presence did not influence the risk of HCC recurrence (55% vs 41%, P=0.280). In contrast, patients with postoperative presence had a significantly higher recurrence (90% vs31%, P<0.001; odds ratio 19.2; 95% confidence interval: 4.0-91.7). In the multivariate analysis by COX proportional hazards model, postoperative positivity had a significant influence on recurrence (P=0.067) and recurrence related mortality (P=-0.017). Whereas, the perioperative positivity of hAFP mRNA did not increase HCC recurrence (58% vs.39% , P=0.093). The correlation between perioperative hAFP mRNA positivity and recurrence related mortality had no statistical significance (P=0.836). CONCLUSION: From our study, perioperative detection of hAFP mRNA in peripheral blood of patients has no clinical relevance and significant role in the prediction of HCC recurrence. Surgical resection itself may not accelerate cancer dissemination and does not increase postoperative recurrence significantly either. AIM:This study was to investigate whether surgery could increase cancer dissemination and postoperative recurrence in patients with hepatocellular carcinoma (HCC) by detection of human α-fetoprotein messenger RNA (hAFP mRNA),hAFP mRNA in the peripheral blood of patients with HCC has been considered as a surrogate marker for circulating tumor cells. METHODS:Eighty-one consecutive patients who underwent curative resection for HCC entered this prospective cohort study.We examined hAFP mRNA from the peripheral blood obtained preoperatively,perioperatively,and postoperatively to correlate the prognosis after curative resections from HCC patients and from the control subjects.Detection of hAFP mRNA by reverse transcriptase and polymerase chain reaction amplification (RT-PCR) was performed with primers specifically.The relations between the clinical variables (age, sex,associated liver cirrhosis,hepatitis B virus infection, hepatitis C virus infection,serum α-fetoprotein and Child- Pugh class),the histological variables (size,capsule,vascular permeation,grade of differentiation,and daughter nodules), hAFP mRNA in peripheral blood of 3 different sessions,and postoperative course (recurrence,and recurrence related death) were analysed. RESULTS:No hAFP mRNA was detected in control group subjects.Twenty-two (27%),24 (30%) and 19 (23%) of 81 HCC patients had hAFP mRNA positivity in the preoperative, perioperative and postoperative peripheral blood.The preoperative presence did not influence the risk of HCC recurrence (55% vs 41%,P=0.280).In contrast,patients with postoperative presence had a significantly higher recurrence (90% vs 31%,P<0.001;odds ratio 19.2;95% confidence interval:4.0-91.7).In the multivariate analysis by COX proportional hazards model,postoperative positivity had a significant influence on recurrence (P=0.067) and recurrence related mortality (P=0.017).Whereas,the perioperative positivity of hAFP mRNA did not increase HCC recurrence (58% vs.39%,P=0.093).The correlation between perioperative hAFP mRNA positivity and recurrence related mortality had no statistical significance (P=0.836). CONCLUSION:From our study,perioperative detection of hAFP mRNA in peripheral blood of patients has no clinical relevance and significant role in the prediction of HCC recurrence.Surgical resection itself may not accelerate cancer dissemination and does not increase postoperative recurrence significantly either.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第1期31-36,共6页 世界胃肠病学杂志(英文版)
基金 Supported by the grants from the Department of Health,National Science Council,Executive Yuan,Taiwan (Dr.Jeng) (NSC 86-2314-B-95-001)
  • 相关文献

参考文献46

  • 1Anonymous. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Liver Cancer Study Group of Japan. Ann Surg 1990; 211:277-287.
  • 2Lee CS, Hwang LY, Beasely RP, Hsu HC, Lee HS, Lin TY. Prognostic significance of histologic findings in resected small hepatocellular carcinoma. Acta Chir Scand 1988; 154:199-203.
  • 3Lai EC, Ng IO, Ng MM, Lok AS, Tam PC, Fan ST, Choi TK, WongJ. Long term results of resection for large hepatocellular carcinoma: A multivariate analysis of clinicopathological features.Hepatology 1990; 11:815-818.
  • 4Jeng KS, Chen BF, Lin HJ. En bloc resection for extensive hepatocellular carcinoma: Is it advisable? World J Surg 1994; 18:834-839.
  • 5Goldblatt SA, Nadel EM. Cancer cells in the circulating blood: acritical review. Acta Cvtol 1965; 305:6-20.
  • 6Glaves D. Correlation between circulation cancer cells and incidence of metastases. Br J Cancer 1983; 48:665-673.
  • 7Fidler IJ. The biology of human cancer metastasis. 7^th Jan Waldenstron lecture. Acta Oncol 1991; 30:668-675.
  • 8Raper SR. Answering questions on a microscopic scale: the detection of circulation cancer cells. Surgery 1999; 126:827-828.
  • 9Eschwege P, Dumas F, Blanchet P, Le Maire V, Benoit G, Jardin A, Lacour B, Loric S. Haematogeneous dismination of postatic epithelium cells during radical prostatecmy. Lancet 1995; 346:1528-1530.
  • 10Warr RP, Zebedee Z, Kenealy J, Rigby H, Kemshead JT. Detection of melanoma seeding during surgical procedures - an RT-PCR based model. Eur I Surg, Oncol 2002: 28:832-837.

同被引文献58

  • 1Yan Li Zhao-You Tang Sheng-Long Ye Yin-Kun Liu Jie Chen Qiong Xue Jun Chen Dong-Mei Gao Wei-Hua Bao Liver Cancer Institute and Zhongshan Hospital of Fudan University (Former Liver Cancer Institute of Shanghai Medical University),Shanghai 200032,China.Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97[J].World Journal of Gastroenterology,2001,7(5):630-636. 被引量:113
  • 2J-MRegimbeau,J.Belghiti.Recurrence after resection of hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2002,1(3):401-405. 被引量:2
  • 3梁水庭,覃晓,黎乐群,陆云飞,覃忠,林进令,巫山,梁雪婧,周惠森.软坚护肝片及甘草甜素片对肝癌术后复发的干预性研究[J].临床肝胆病杂志,2004,20(5):293-294. 被引量:11
  • 4Bao-GangPeng Li-JiangLiang QiangHe MingKuang Jia-MingLia Ming-DeLu Jie-FuHuang.Tumor vaccine against recurrence of hepatocellular carcinoma[J].World Journal of Gastroenterology,2005,11(5):700-704. 被引量:28
  • 5Umberto Cillo,Alessandro Vitale,Filippo Navaglia,Daniela Basso,Umberto Montin,Marco Bassanello,Francesco D'Amico,Francesco Antonio Ciarleglio,Alberto Brolese,Giacomo Zanus,Vito De Pascale,Mario Plebani,Davide Francesco D'Amico.Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatoceiluiar carcinoma[J].World Journal of Gastroenterology,2005,11(44):6920-6925. 被引量:12
  • 6Masaki Kaibori M.D.,Yoichi Matsui M.D.,Hidesuke Yanagida M.D.,Norio Yokoigawa M.D.,A-Hon Kwon M.D.,Yasuo Kamiyama M.D.Positive Status of α-Fetoprotein and des-γ-Carboxy Prothrombin: Important Prognostic Factor for Recurrent Hepatocellular Carcinoma[J].World Journal of Surgery.2004(7)
  • 7Zhao-You Tang,Sheng-Long Ye,Yin-Kun Liu,Lun-Xiu Qin,Hui-Chuan Sun,Qin-Hai Ye,Lu Wang,Jian Zhou,Shuang-Jian Qiu,Yan Li,Xue-Ning Ji,Hu Liu,Jing-Ling Xia,Zhi-Quan Wu,Jia Fan,Zeng-Chen Ma,Xin-Da Zhou,Zhi-Ying Lin,Kang-Da Liu.A decade’s studies on metastasis of hepatocellular carcinoma[J].Journal of Cancer Research and Clinical Oncology.2004(4)
  • 8Atsushi Nanashima,Kenji Tanaka,Hiroyuki Yamaguchi,Shinichi Shibasaki,Shigeyuki Morino,Megumi Yoshinaga,Terumitsu Sawai,Tohru Nakagoe,Hiroyoshi Ayabe.Fibrosis and Inflammatory Activity in Noncancerous Tissue and Mitotic Index of Cancer Tissue in Patients with Hepatocellular Carcinoma: Relationship to Clinicopathological Factors and Prognosis After Hepatic Resection[J].Digestive Diseases and Sciences.2003(8)
  • 9Yee Chao MD, PhD,Chung-Ping Li MD,Gar-Yang Chau MD,Chih-Ping Chen MD,Kuang-Liang King MD,Wing-Yiu Lui MD, PhD,Sang-Hue Yen MD,Full-Young Chang MD,Wing-Kai Chan MD,Shou-Dong Lee MD.Prognostic Significance of Vascular Endothelial Growth Factor, Basic Fibroblast Growth Factor, and Angiogenin in Patients With Resectable Hepatocellular Carcinoma After Surgery[J].Annals of Surgical Oncology.2003(4)
  • 10Yi-Hsiang Huang,Jaw-Ching Wu,Wing-Yiu Lui,Gar-Yang Chau,Shih-Haw Tsay,Jen-Huey Chiang,Kuang-Liang King,Teh-Ia Huo,Full-Young Chang,Shou-Dong Lee.Prospective Case-controlled Trial of Adjuvant Chemotherapy after Resection of Hepatocellular Carcinoma[J].World Journal of Surgery.2000(5)

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部